Adam Cooper

Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma

Elin S. Gray, Helen Rizos, Anna Reid et al. · Oncotarget · 2015 · 322 citations · Full text

Baseline Ctdna Levels, Immunology, Pathology +18

Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma

Ricardo E. Vilain, Alexander M. Menzies, James S. Wilmott et al. · Clinical Cancer Research · 2017 · 243 citations · Full text

Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma

Elizabeth Liniker, Alexander M. Menzies, Benjamin Y. Kong et al. · OncoImmunology · 2016 · 150 citations · Full text

Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes

Mohammed Nimir, Yafeng Ma, Sarah A. Jeffreys et al. · Cells · 2019 · 64 citations · Full text

Androgen Receptor, Engineering, Circulating Tumor Cells +16

Preliminary results of a phase I/IIa study of BMS-986156 (glucocorticoid-induced tumor necrosis factor receptor–related gene [GITR] agonist), alone and in combination with nivolumab in pts with advanced solid tumors.

Lillian L. Siu, Neeltje Steeghs, Tarek Meniawy et al. · Journal of Clinical Oncology · 2017 · 53 citations

Immunology, Pharmacotherapy, Immunotherapeutics +17